Sevi Duo HCT Tablet 5/40/12.5 mg

Adult dose

This medication is taken as 1 tablet once daily, with or without food, and is recommended to be taken at the same time every day (e.g., in the morning). The recommended dosing regimens are as follows: - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20mg combination therapy. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40mg combination therapy.

Child dose

The safety and efficacy in pediatric patients under 18 years of age have not been established, hence the use of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. It should not be taken by individuals who have allergies to any of its ingredients or similar substances, or have a history of such allergies. Patients with specific health conditions such as severe hypotension, severe heart disease, or acute kidney function decline should also avoid this medication. Patients with reduced blood volume or impaired kidney function should be closely monitored while taking this medication, as hypotension or worsening kidney function may occur. Patients with impaired liver function or progressive liver disease should be cautious, as hepatic coma may occur when using this medication. Since this medication lowers blood pressure, caution is required while driving or operating machinery due to the possibility of dizziness. During the course of taking this medication, regular checks should be performed on blood electrolyte levels and kidney function to ensure there are no abnormalities. Interactions may occur when this medication is taken with other antihypertensives or diuretics, so it is essential to consult a doctor or pharmacist. Photosensitivity reactions may occur, so excessive exposure to sunlight should be avoided, and any skin abnormalities should be reported immediately. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established. Elderly individuals may have reduced kidney and liver function, so it is advisable to start with a low dose and administer it carefully. Overdosage may lead to symptoms such as hypotension, palpitations, and dehydration, so the dosage should be strictly adhered to. When storing, keep it out of reach of children and avoid moisture, heat, and direct sunlight.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucous membranes, shortness of breath or breathing difficulties, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the effectiveness of the medication for a longer period.

Appearance

Pale yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTPX2)